Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Dual Orexin Receptor Antagonist, Lemborexant, on Total Sleep Time in Shift Workers: a Randomized Controlled Trial

NCT05344443 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05344443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05344443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Dual Orexin Receptor Antagonist, Lemborexant, on Total Sleep Time in Shift Workers: a Randomized Controlled Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
March 10, 2022
Completion date
November 30, 2024
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

shift-work related sleep disturbance